Q1 2025 · 13F-HR
Samsara BioCapital, LLCholdings as filed
Filed 2025-05-15 · accession 0001415889-25-013106
$560.8M
Reported value
37
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $180.5M | 32.2% | 5,612,896 | Common | SOLE |
| 482929106 | KLRS | KALARIS THERAPEUTICS INC | $91.9M | 16.4% | 11,448,081 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $90.1M | 16.1% | 5,674,916 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $20.1M | 3.59% | 1,717,127 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $20.1M | 3.58% | 3,266,498 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $19.0M | 3.39% | 679,486 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $18.2M | 3.25% | 3,149,128 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $18.0M | 3.20% | 4,415,689 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $13.5M | 2.41% | 526,390 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $12.7M | 2.26% | 2,067,146 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $8.9M | 1.58% | 135,276 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $7.9M | 1.42% | 666,667 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $7.6M | 1.35% | 967,527 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.3M | 1.30% | 138,118 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $6.9M | 1.24% | 3,768,035 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $6.7M | 1.20% | 6,130,268 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $6.2M | 1.11% | 2,523,022 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $4.1M | 0.73% | 588,816 | Common | SOLE |
| 918385204 | VTVT | VTV THERAPEUTICS INC | $3.6M | 0.64% | 206,784 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $3.5M | 0.63% | 824,155 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $2.8M | 0.50% | 241,400 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $2.7M | 0.47% | 425,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $1.4M | 0.25% | 2,196,814 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $1.4M | 0.25% | 1,562,500 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $874,998 | 0.16% | 291,666 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $863,100 | 0.15% | 630,000 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $806,404 | 0.14% | 405,228 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $745,162 | 0.13% | 2,442,352 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $579,474 | 0.10% | 399,637 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $558,480 | 0.10% | 202,348 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $419,661 | 0.07% | 1,049,153 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $390,480 | 0.07% | 185,943 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $175,573 | 0.03% | 1,390,130 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $64,458 | 0.01% | 78,131 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $42,667 | 0.01% | 133,333 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $39,167 | 0.01% | 172,089 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,000 | 0.00% | 99,999 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.